AbCellera Biologics Inc. (ABCL) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 664.6M | 728.23M | 695.14M | 742.14M | 764.98M | 751.37M | 742.88M | 771.55M | 813.95M | 871.99M | 919.52M | 930.74M |
| Cash & Short-Term Investments | 504.73M | 560.33M | 495.67M | 553.08M | 605.27M | 625.61M | 643.14M | 670.36M | 698.02M | 760.59M | 785.84M | 795.69M |
| Cash Only | 77.06M | 155.01M | 83.16M | 92.44M | 159.27M | 156.32M | 126.64M | 148.31M | 123.57M | 133.32M | 172.42M | 179.75M |
| Short-Term Investments | 427.67M | 405.31M | 412.51M | 460.64M | 446M | 469.29M | 516.5M | 522.04M | 574.45M | 627.26M | 613.42M | 615.95M |
| Accounts Receivable | 115.72M | 153.4M | 159.36M | 153.37M | 126.61M | 92.13M | 63.24M | 67.7M | 68.78M | 64.38M | 75.48M | 86.23M |
| Days Sales Outstanding | 1.46K | 320.76 | 1.61K | 745.68 | 2.32K | 1.42K | 925.65 | 847.98 | 608.66 | 700.92 | 1.13K | 840.69 |
| Inventory | 0 | 6.34M | 0 | 0 | 0 | 0 | 0 | 0 | 738K | 1.11M | 1.19M | 1.45M |
| Days Inventory Outstanding | - | 73.6 | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 44.14M | 8.17M | 40.11M | 35.7M | 33.1M | 33.63M | 36.51M | 33.49M | 21.41M | 45.91M | 25M | 25M |
| Total Non-Current Assets | 642.52M | 628.72M | 660.85M | 659.92M | 579.23M | 609.18M | 649.95M | 640.93M | 649.15M | 616.11M | 592.67M | 606.43M |
| Property, Plant & Equipment | 422.81M | 428M | 427.36M | 424.02M | 347.1M | 340.43M | 331.26M | 318.88M | 306.08M | 287.7M | 277.21M | 259.64M |
| Fixed Asset Turnover | 0.02x | 0.10x | 0.02x | 0.04x | 0.01x | 0.02x | 0.02x | 0.02x | 0.03x | 0.03x | 0.02x | 0.04x |
| Goodwill | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Intangible Assets | 37.46M | 38.38M | 39.32M | 40.26M | 41.19M | 42.11M | 52.58M | 85.66M | 118.74M | 120.42M | 124.08M | 126.75M |
| Long-Term Investments | 65.31M | 62.58M | 93.3M | 90.37M | 81.57M | 82.3M | 84.08M | 130.76M | 122.09M | 65.94M | 62.89M | 58.79M |
| Other Non-Current Assets | 69.14M | 51.95M | 53.07M | 57.45M | 61.56M | 96.54M | 134.22M | 57.81M | 54.43M | 94.24M | 80.69M | 113.45M |
| Total Assets | 1.31B | 1.36B | 1.36B | 1.4B | 1.34B | 1.36B | 1.39B | 1.41B | 1.46B | 1.49B | 1.51B | 1.54B |
| Asset Turnover | 0.01x | 0.03x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.00x | 0.01x |
| Asset Growth % | -2.76% | -0.26% | -2.64% | -0.74% | -8.13% | -8.57% | -7.89% | -8.11% | -2.32% | -3.43% | -2.59% | -3.55% |
| Total Current Liabilities | 47.29M | 64.31M | 68.8M | 67.02M | 75.4M | 76.61M | 79.57M | 70.38M | 104.88M | 119.01M | 110.24M | 118.91M |
| Accounts Payable | 20.81M | 25.23M | 31.77M | 32.04M | 32.8M | 34.35M | 34.8M | 26.59M | 26.91M | 28.6M | 17.43M | 21.02M |
| Days Payables Outstanding | 239.36 | 331.07 | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 5.87M | 5.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 7.74M | 13.53M | 24.63M | 25.12M | 26M | 21.18M | 13.44M | 6.4M | 10.56M | 26.07M | 23.86M | 15.06M |
| Other Current Liabilities | 12.87M | 8.98M | 0 | 0 | 0 | 0 | 0 | 27.43M | 59.03M | 50.48M | 57.02M | 57.97M |
| Current Ratio | 14.05x | 11.32x | 10.10x | 11.07x | 10.15x | 9.81x | 9.34x | 10.96x | 7.76x | 7.33x | 8.34x | 7.83x |
| Quick Ratio | 14.05x | 11.23x | 10.10x | 11.07x | 10.15x | 9.81x | 9.34x | 10.96x | 7.75x | 7.32x | 8.33x | 7.82x |
| Cash Conversion Cycle | - | 63.29 | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 145.63M | 151.29M | 323.15M | 327.96M | 245.83M | 227.86M | 235.17M | 231.13M | 228.3M | 216.76M | 219.18M | 223.43M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 134.31M | 137.4M | 137.05M | 137.18M | 63.21M | 60.74M | 66.27M | 66.45M | 68.08M | 71.22M | 75.19M | 78.08M |
| Deferred Tax Liabilities | 0 | 9.12M | 9.74M | 10.05M | 10.05M | 10.05M | 12.78M | 21.74M | 30.27M | 30.61M | 33.18M | 33.18M |
| Other Non-Current Liabilities | 11.32M | 4.77M | 1.39M | 1.56M | 1.62M | 1.47M | 5.96M | 10.79M | 10.8M | 10.82M | 10.36M | 8.11M |
| Total Liabilities | 192.92M | 215.59M | 391.95M | 394.99M | 321.23M | 304.47M | 314.73M | 301.51M | 333.18M | 335.78M | 329.42M | 342.34M |
| Total Debt | 140.18M | 143.22M | 142.22M | 142.08M | 67.85M | 65.36M | 71.4M | 72.05M | 73.61M | 77.38M | 80.76M | 84.03M |
| Net Debt | 63.12M | -11.79M | 59.06M | 49.64M | -91.42M | -90.96M | -55.24M | -76.26M | -49.96M | -55.94M | -91.67M | -95.72M |
| Debt / Equity | 0.15x | 0.13x | 0.15x | 0.14x | 0.07x | 0.06x | 0.07x | 0.06x | 0.07x | 0.07x | 0.07x | 0.07x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 938.08M | 1.14B | 964.04M | 1.01B | 1.02B | 1.06B | 1.08B | 1.11B | 1.13B | 1.15B | 1.18B | 1.19B |
| Equity Growth % | -8.3% | 8.07% | -10.58% | -9.35% | -9.46% | -8.35% | -8.85% | -7.02% | -6.5% | -6.56% | -5.39% | -1.49% |
| Book Value per Share | 3.10 | 3.82 | 3.23 | 3.37 | 3.44 | 3.58 | 3.66 | 3.78 | 3.86 | 3.96 | 4.09 | 4.14 |
| Total Shareholders' Equity | 938.08M | 1.14B | 964.04M | 1.01B | 1.02B | 1.06B | 1.08B | 1.11B | 1.13B | 1.15B | 1.18B | 1.19B |
| Common Stock | 816.53M | 802.34M | 794.47M | 791.67M | 790.07M | 777.17M | 772.83M | 769.97M | 764.56M | 753.2M | 747.91M | 744.76M |
| Retained Earnings | -72.65M | -29.48M | -20.54M | 36.58M | 71.31M | 116.93M | 151.14M | 202.25M | 239.18M | 279.79M | 326.94M | 355.55M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.42M | -4.23M | -2.7M | -2.66M | -7M | -4.38M | -1.23M | -2.07M | -1.82M | -1.72M | -1.46M | -1.9M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |